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Abstract
Background: Every year more than 200,000 new leprosy cases are registered globally. This number has been fairly
stable over the past 8 years. WHO has set a target to interrupt the transmission of leprosy globally by 2020. The aim
of this study is to investigate whether this target, interpreted as global elimination, is feasible given the current
control strategy. We focus on the three most important endemic countries, India, Brazil and Indonesia, which
together account for more than 80 % of all newly registered leprosy cases.
Methods: We used the existing individual-based model SIMCOLEP to predict future trends of leprosy incidence given
the current control strategy in each country. SIMCOLEP simulates the spread of M. leprae in a population that is
structured in households. Current control consists of passive and active case detection, and multidrug therapy (MDT).
Predictions of leprosy incidence were made for each country as well as for one high-endemic region within each
country: Chhattisgarh (India), Pará State (Brazil) and Madura (Indonesia). Data for model quantification came from:
National Leprosy Elimination Program (India), SINAN database (Brazil), and Netherlands Leprosy Relief (Indonesia).
Results: Our projections of future leprosy incidence all show a downward trend. In 2020, the country-level leprosy
incidence has decreased to 6.2, 6.1 and 3.3 per 100,000 in India, Brazil and Indonesia, respectively, meeting the
elimination target of less than 10 per 100,000. However, elimination may not be achieved in time for the high-endemic
regions. The leprosy incidence in 2020 is predicted to be 16.2, 21.1 and 19.3 per 100,000 in Chhattisgarh, Pará and
Madura, respectively, and the target may only be achieved in another 5 to 10 years.
Conclusions: Our predictions show that although country-level elimination is reached by 2020, leprosy is likely to
remain a problem in the high-endemic regions (i.e. states, districts and provinces with multimillion populations), which
account for most of the cases in a country.
Background
Leprosy or Hansen disease is caused by an infection of
Mycobacterium leprae, usually acquired through contact
with an infected person. However, not everyone exposed
to an infected contact will eventually develop the disease
[1]. Worldwide, more than 200,000 new leprosy cases are
detected annually [2]. This number has been fairly stable
in the past 8 years, indicating ongoing transmission.
In 2013, 14 countries reported more than 1000 new cases,
of which three countries - India, Brazil and Indonesia -
account for more than 80 % of all the cases in the world
[2]. The distribution of leprosy is becoming localized to a
limited number of countries [2]. Also within countries
leprosy is found to be spatially unevenly distributed [3, 4].
The spread of leprosy in a population is highly
dependent of the variation in susceptibility of individuals
and the intensity of contact with other individuals [5, 6].
As a result leprosy patients are often found to be
spatially clustered in regions, neighborhoods, families
and households [7–9]. Contacts closest to the index
patient, in particular household contacts, have the
highest risk [5, 8].
Leprosy patients are treated with a combination of
antibiotics known as multidrug therapy (MDT), which
effectively heals the patient and thereby also reduces the
infectivity in the community. However, MDT alone is
not sufficient to prevent new cases. Therefore the main
principles of leprosy control also include early detection
of leprosy cases [2]. Other methods of prevention such
as immunoprophylaxis and chemoprophylaxis against
M. leprae are not yet widely available [10].
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Global elimination of leprosy has been a target for a
long time. In 1991, the 44th World Health Assembly
already adopted the target of elimination as a public
health problem, defined as reducing the prevalence to
less than 1 case per 10,000 population by the year 2000
[11]. Although this target was met at a global level, elim-
ination of leprosy as a public health problem has not
been achieved in some endemic countries, in particular
at a subnational level [2]. Recently, WHO has formu-
lated a roadmap for 17 neglected tropical diseases, in-
cluding leprosy, to reduce their global impact. The
targets for leprosy are (1) global interruption of trans-
mission or elimination by 2020, and (2) reduction of
grade-2 disabilities in newly detected cases to below 1
per million population at global level by 2020 [12].
The aim of this study is to investigate whether the first
target is feasible given the current control strategy. To be
able to assess this, we interpreted the first target of 'inter-
ruption of transmission' in terms of incidence reduction,
contrary to the original WHO elimination target (as pub-
lic health problem), which was defined in terms of preve-
lance reduction. Our operational definition of global
elimination of leprosy as applied in this paper is: 'less than
10 new cases per 100,000 population. We focus on the
three countries with the highest number of annual new
cases: India, Brazil and Indonesia. Since leprosy is spatially
unevenly distributed within countries, we will for com-
parison also make predictions for one high-endemic re-
gion within each country: Chhattisgarh (India), Pará State
(Brazil) and Madura Island (Indonesia). We will use the
existing individual-based model SIMCOLEP, which simu-
lates the transmission and control of leprosy in a popula-
tion structured by households [6, 13]. This model has
been previously quantified to the leprosy situation in
northwest Bangladesh with the aim of making future
predictions of leprosy trends and testing the impact
of various interventions [14].
In this study, we apply SIMCOLEP to make predic-
tions of future leprosy incidence in India, Brazil,
Indonesia and aforementioned regions until the year
2030. For each of these countries and regions, we will
assess whether elimination, defined as less than 10 new
cases per 100,000, will be met by 2020 given continu-
ation of the current control strategies of MDT treatment
and early detection.
Methods
Model
The individual-based model SIMCOLEP simulates the
spread of M. leprae in a population structured in house-
holds. Dynamics of the population are described by
births, movements between households, and deaths.
Births are determined by birth rates and newborns are
placed in the household of their mother. Movements of
individuals to another newly created or existing house-
hold occur after marriage, during adolescence or after
becoming a widow(er). Deaths are determined by death
rates [6].
In the model, transmission of M. leprae occurs after
direct contact with an infectious individual. Two trans-
mission processes are modelled separately: transmission
in the general population and a within-household trans-
mission. Infectivity is determined by the product of the
contact rate and the probability of infection during a
contact. Each transmission process has its own contact
rate: general population, cpop, and within households,
chh. An infected individual will develop either paucibacil-
lary leprosy (PB) or multibacillary leprosy (MB). Both
types can be detected, treated and cured, but only MB
leprosy is considered infectious in the model. The nat-
ural history of leprosy is modelled following the model
of Meima et al. [15].
Leprosy can only be acquired by susceptible individ-
uals. It is assumed that the majority of the population is
never susceptible to leprosy [6]. Since the mechanism
that underlies susceptibility is still unknown and could
not be identified in previous (modelling) work, suscepti-
bility of an individual is randomly determined at birth.
We assumed that 20 % of the population is susceptible
(i.e. 80 % is never susceptible), based on model fitting re-
sults of a previous study [6]. The type of leprosy (i.e. MB
or PB) is randomly determined based on the distribution
of the type of leprosy in each country. The MB propor-
tion is about 48 %, 66 %, and 83 % in India, Brazil, and
Indonesia, respectively.
Model fitting and data
The model was fitted to the leprosy situation in India,
Brazil and Indonesia, and to one high-endemic region
in each of those countries. First, we fitted the popula-
tion of each country to simulate the overall population
and household structure. Population sizes differed
between countries and regions: India (1.2 billion),
Chhatisgarh (27 million), Brazil (200 million), Pará
State (8 million), Indonesia (250 million), Madura (3.6
million) (See Additional file 1: Figure S1). The popula-
tion in each country and region is quantified using
country-specific demographic data as input, including:
population growth rates, birth rates, death rates, fertil-
ity rates and the age distribution. These data were ob-
tained from various sources including country census,
Demographic and Health surveys (DHS) and WHO
(see Table 1). Parameters that regulate movements of
individuals between households were calibrated such
that the simulated distribution of household size
matched the observed distribution. Non-married
young males can move out of their parent’s household
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Table 1 Overview of data used to quantify the model
India Brazil Indonesia
Years Source Years Source Years Source
Demographic data:
Population growth 1901–2011 Census India 1872–2010 Census Brazil 1850–2010 Census Indonesia (BPS)
Fraction married 2001, 2011 Census India 1990, 2000, 2010 IBGEc 1993, 1997, 2000, 2007 IFLSe
Survival rates 1990, 2000, 2012 WHO 1991, 2000, 2010 IBGEc 1990, 2000, 2009 WHO
Fertility rates 1992, 1998 , 2006, 2011, 2012, 2013 DHSa, Census India 1991, 1995, 2000, 2005, 2010 IBGEc 1971, 1980, 1990, 1991, 1997, 2003, 2007, 2012 DHSa
Age distribution 2013 DHSa 1990, 2000, 2010 IBGEc 2012 DHSa
Distribution of
household size
1993, 1999, 2006 DHSa 1990, 2000 IBGEc 1991, 1994, 1997, 2003, 2007 DHSa
Epidemiological data:
New case detection rate
- Country 1991–2015 NLEPb 1990–2014 SINANd 2000–2013 NLRf
- High-endemic region 2008–2015 NLEPb 1990–2014 SINANd 2001–2010 NLRf
MB proportion 2011–2013 NLEPb 2001–2012 SINANd 2000–2013 NLRf
BCG coverage 1980–2013 WHO 1980–2013 WHO 1980–2013 WHO
aDemography and Household Survey; bNational Leprosy Elimination Programme; cBrazilian Institute of Geography and Statistics; dSistema de Informações de Agravos de Notificação; eIndonesian Family Life Survey;
fNetherlands Leprosy Relief foundation
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to either start their own household or move to another
household. The age of moving is 12 to 22 years in
Brazil and Indonesia and 18 to 28 years in India. The
fraction of non-married males that moves during ado-
lescence is 98 %, 75 %, and 100 % in India, Brazil and
Indonesia respectively. One percent of these moving
males in Brazil and none in the other countries will
create their own household. The other moving males
will go to an existing household, which is randomly de-
termined weighed by size of the households following
a Triangular distribution (India: Tri(0,4,3); Brazil and
Indonesia: Tri(0,4,2). In all countries all widows and
widowers in one person households move to multi per-
son households (i.e. children) at the moment of be-
coming widow(er). The quantifications of other
household parameters were similar to previous work
(See Addtional file 1: Table S1) [6]. We assumed that
household structures in each region were similar to the
household structures of the whole country. Data on
household size distributions were obtained from DHS.
Goodness of fit of the distribution of household size
was evaluated by a Chi-square test.
After fitting the population and household structure
in each country, we fitted the simulated leprosy
trends to the observed trends in each country and re-
gion separately. Data used to fit leprosy trends in-
clude the new case detection rate and the MB
proportion. Indian data were obtained from the
National Elimination Program (NLEP) [16]. Brazil
leprosy data came from the Sistema de Informações
de Agravos de Notificação (SINAN) database [17].
The SINAN database is the Brazilian national data-
base for communicable diseases. Finally, leprosy data
for Indonesia were provided by the Netherlands
Leprosy Relief (NLR) foundation (see Table 1).
In order to fit the leprosy trends, we also modeled
leprosy control programs of the past decades in each
country. The leprosy control program consisted of
treatment with Dapsone until 1989 and MDT afterwards,
and passive and active case detection. Changes in passive
detection were expressed in terms of detection delays.
These detection delays were fitted to match the trends
of the new case detection rates. Based on literature, most
recent detection delays were set to 2–3 years in our
model [18]. The estimated detection delays gradually im-
proved since 1970 from 13 to 2 years, 18 to 3 years, and
10 to 2 years (gamma distributed) in India, Brazil and
Indonesia, respectively. Active case detection, defined as
examining contacts of the patient, was only included if
data about coverage rates were available. In Indonesia
active detection was included since 2010 with a coverage
rate of 9–11 %. In Brazil the coverage rate was between
43 and 59 %, and started since 2003 [19]. No active case
detection was included in India [20]. BCG vaccination in
infants, which has a protective effect of 60 %, was also
included [21]. Coverage rates of BCG vaccination in in-
fants, obtained from WHO, were used [22]. We further
assumed that the national leprosy control strategy was
implemented consequently within regions.
Leprosy new case detection rates were fitted to the
data by calibrating contact rates. In this study, we only
calibrated the contact rate in the general population.
Since no data was available about the prevalence and/or
incidence of leprosy by household size and per house-
hold member, we fixed the contact rate within house-
hold to the optimal value of previous work (chh = 0.98)
[6]. We assumed that contact rates within households
would not differ between countries and regions. The
contact rate in general population (cpop) of each country
and region was estimated separately by fitting the simu-
lated new case detection rates to the observed new case
detection rates from the data (see Table 1). To this end,
the simulated new case detection rates (mean of 100
runs) were compared to the data by a log-likelihood
function assuming a Poisson distribution. These likeli-
hood ratios were fitted to a polynomial regression meta-
model to obtain the optimal cpop value.
New simulations were performed with the optimal cpop
values. A detailed description of the fitting procedure can
be found elsewhere [6]. A manual of the model, the model
itself and the input files with country-specific quantifica-
tions are provided in Additional file 2 and Additional file 3.
Future projections
Using the best fit for each country and high-endemic re-
gion, we made future predictions assuming continuation
of current leprosy control programs: MDT treatment,
passive detection and active detection (only Brazil and
Indonesia). Each simulation run starts in the year 1000
with a modelled population size of 20,000 individuals
that remains constant until 1850–1900. Afterwards the
population increase with the annual growth rate to more
than 125,000 individuals in 2030. All simulations contin-
ued to the year 2030 to predict future trends and to
determine whether elimination could be reached by
2020. Simulation results were an average of 100 runs.
Results
Results of calibration of the household structure in the
population are shown in Figure 1. In each country, the
simulated household structure closely resembled the ob-
served distribution of household sizes. Using these
household structures, the trends in leprosy new case
detection rates were fitted to the observed data. The
optimal values of the contact rates are: 0.970 (95 % CI:
0.929-1.011; India), 1.679 (95 % CI: 1.638-1.720; Chhat-
tisgarh), 0.367 (95 % CI: 0.326-0.408; Brazil), 0.543 (95 %
CI: 0.503-0.584; Pará State), 0.104 (95 % CI: 0.063-0.145;
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Indonesia), and 0.235 (95 % CI: 0.194-0.276; Madura).
Figure 2 shows that in all scenarios our model was able
to reproduce the observed trends. Madura shows a poor
fit for the years 2001–2003, given the operational
changes in leprosy control that were considered at na-
tional level. Also the simulated MB proportion in each
country matched the proportion in data (See Additional
file 1: Figure S2).
Figure 3 shows the predicted new case detection rate
trends until 2030 for India, Brazil and Indonesia, assum-
ing that current national leprosy control programs will
continue unchanged. For all three countries a substantial
decline in new case detection rate can be observed until
2030. On a country-level, the elimination target of less
than 10 per 100,000 has already been met in India and
Indonesia, and will be met by 2016 in Brazil. In 2020,
the predicted new case detection rates are 6.2 (90 % CI:
2.6-10.2), 6.1 (90 % CI: 3.4-8.7), and 3.3 (90 % CI: 1.8-
5.2) new cases per 100,000 in India, Brazil and
Indonesia, respectively. The predicted annual decrease
between 2015 and 2030 is approximately 10.5 %, 9.1 %,
and 8.1 % in India, Brazil and Indonesia, respectively.
The new case detection rates in the regions
Chhattisgarh, Pará State and Madura are 2–7 times
Fig. 1 Result of calibration of the household structure in the population to the observed distribution of household size in India (2006), Brazil
(2000), and Indonesia (2007). There is no significant difference between data and the simulated distributions (χ2-test)
Blok et al. Parasites & Vectors  (2015) 8:548 Page 5 of 9
higher than the national rates. Similarly to country-
level predictions, the new case detection rates in the
high-endemic regions will continue to drop over time.
However, in these regions the elimination target will
not be met in time. In 2020, the predicted new case
detection rates are 16.2 (90 % CI: 9.4-24.7), 21.1
(90 % CI: 16.9-24.2), and 19.3 (90 % CI: 15.9-23.3)
per 100,000 in Chhattisgarh, Pará State, and Madura,
respectively. Elimination in these regions will not be
established before 2026. The annual decrease between
2015 and 2030 is about 8.7 %, 8.4 %, and 7.2 % in
Chhattisgarh, Pará State, and Madura, respectively.
Predictions in terms of annual new cases are shown
in Additional file 1: Figure S3.
The distribution of new leprosy cases by age group
differs by country and is affected by control strategies.
Improved detection will mainly increase the detection
of older individuals (See Additional file 1: Figure S4).
Also the distribution of new leprosy cases by household
size differs by country. In Brazil most cases are found
in bigger households, while in Indonesia most cases are
found in smaller households (See Additional file 1:
Figure S5).
Discussion
We used the individual-based model SIMCOLEP to
assess whether the WHO target of elimination of
leprosy, defined as less than 10 new cases per 100,000
annually, would be met by 2020. We focused on three
high-endemic countries, India, Brazil and Indonesia,
which account for more than 80 % of all cases world-
wide. Our study shows that elimination of leprosy in
these countries has already been met or will be met in
the very near future at country-level. However, in the
high-endemic regions of these countries – Chhattisgarh,
Pará State and Madura – elimination of leprosy will not
be achieved by 2020 with the current leprosy control
Fig. 2 Result of fitting the new case detection rates to the observed new case detection rate. The solid lines are the result of an average of 100
runs. The shaded area is the 90 % confidence interval (stochastic variation in individual runs)
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strategy. Regional new case detection rates are 2–7 times
higher than at country-level.
Country-level predictions of the new case detection
rates, which suggest elimination, provide a biased view
of the leprosy situation, because these rates are masked
by the large population size of each country. Focusing
on high-endemic regions where this elimination target
has not yet been achieved will give a more realistic rep-
resentation of the actual leprosy situation in a country.
It also reflects more accurately that the distribution of
leprosy is becoming more localized [3, 4, 23].
Our results show a continuous decline in new case de-
tection rates, demonstrating that the present leprosy
control strategy, if consistently applied, will reduce
transmission. Results also show that confidence bounds
become smaller around future projections. This is
caused by the downward trend of the NCDR given the
control strategy and partially by the population growth.
Predictions in terms of annual number of new cases il-
lustrate that confidence bounds decrease less rapidly
when the population growth is not considered (See
Additional file 1: Figure S3 ). The annual rate of decline
is greatest in India, followed by Brazil and Indonesia.
Also within countries the speed of decline differs. This is
caused by differences in intensity of contact, reflecting
different living conditions based on varying socioeco-
nomic and cultural circumstances. In high-endemic re-
gions, which are generally less developed, the calibrated
contact rate in the general population was higher than at
country-level country rates, which reflects a nation-wide
average.
The poorer fit of Madura in Indonesia might be
explained by regions specific operational changes in
control. Madura is an island in Indonesia and therefore
relatively isolated. It has always been a high-endemic
region. The poor fitting is probably the result of the fo-
cused intensified case finding activities in that particular
area between 2003 and 2005 causing the NCDR to
double in that region, which our model did not account
for [24, 25].
Fig. 3 Predicted new case detection rates until 2030 assuming continuation of the present leprosy control strategy. The solid lines are the result
of an average of 100 runs. The shaded area is the 90 % confidence interval (stochastic variation in individual runs)
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The large number of undetected cases remains a threat
to the elimination of leprosy generally. Leprosy is a slow
disease with a long incubation time and long delays in
detection [20, 26, 27]. These missing cases still contrib-
ute to the ongoing transmission. It has been estimated
that over 4 million cases are missed between 2000 and
2020 worldwide [27]. It has been argued that in India
half of the cases have not been reported to meet the
elimination targets of 2005 [20]. Since our model heavily
depends on the available case data, including their im-
perfections, the problem of missing cases is also inherent
to our predictions. On the whole, the actual number of
new leprosy cases is likely to be higher than presented in
our predictions [20, 27, 28].
A concern of this study is that the predictions are
made under the assumption that being susceptibility to
leprosy was fully randomly determined. Previous work
has shown that although this may be a valid assumption,
other mechanisms, such as genetic inheritance of sus-
ceptibility, might also explain variation in susceptibility
[6]. Assuming another mechanism for susceptibility has
proven to somewhat slow down the speed of decline of
the new case detection trends [14]. Our results can
therefore be regarded as a best case scenario.
In our study elimination was defined as less than 10
new cases per 100,000, while elimination is officially de-
fined as a prevalence rate of less than 10 per 100,000
population. This will, however, not alter our conclusions,
because the prevalence rate of leprosy does not differ
much from the new case detection rate.
Furthermore, our predictions are based on a continu-
ation of the present leprosy control strategy, which also
includes some contact tracing in Brazil and Indonesia. It
assumes full adherence to the strategy. Any unexpected
adverse events, such as famines and social upheaval,
have not been considered. On the other hand, our study
also does not account for possible additional leprosy
control practices in regions, such as chemoprophylaxis
for contacts of leprosy cases.
An important next step is to determine which inter-
ventions at population level would bring elimination
forward and have the highest impact on future incidence
of disease through the interruption of transmission. The
focus should be on interventions targeting the contacts
of leprosy patients to prevent new cases [9]. Examples of
such intervention are intensive contact tracing, adminis-
tering chemoprophylaxis or immunoprophylaxis (e.g.
BCG-like leprosy vaccine) and early diagnosis of leprosy
using diagnostic tests for infection or tests that predict
clinical disease.
Conclusion
Although it seems that country-level elimination is
reached by 2020, leprosy still remains a problem in the
high-endemic regions, which account for most of the
cases in a country. These regions often have a multimil-
lion population in which rapid progress of leprosy control,
even if conducted optimally, will not be achieved soon.
We therefore conclude that ongoing transmission of
M. leprae will make global elimination of leprosy as a un-
likely to occur by 2020 without further control measures.
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